Cardiac resynchronization therapy (CRT) is indicated for the treatment of patients with advanced heart failure (HF) symptoms, a left ventricular (LV) ejection fraction (EF) B35 %, and prolonged QRS duration.
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Unfortunately, the sole use of these current patient selection parameters leads to implantation in an estimated third of patients for whom improvement is not demonstrable. 2 Alternatively, using QRS duration as a surrogate for electrical dyssynchrony may lead to the inappropriate exclusion of large segments of the HF population that may benefit from CRT. In recent years, there has been a push towards towards investigating non-invasive imaging methods to accurately define LV mechanical dyssynchrony and thus improve patient selection for CRT.
Quantitative echocardiographic measures derived from techniques such as tissue Doppler imaging (TDI) and strain analysis have been used to identify dyssynchrony, but these methods lack reproducibility and have not consistently been able to discriminate between responders and non-responders to CRT. 3 The use of phase analysis of gated single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) for quantifying mechanical dyssynchrony has been well described in literature. [4] [5] [6] [7] [8] [9] Phase analysis using SPECT MPI can allow the simultaneous assessment of LV function, mechanical dyssynchrony, and location/ extent of scar in a proven very reproducible fashion. Therefore, it has the potential for being an ideal first test in the population of patients being considered for CRT.
Different parameters from this phase analysis technique such as peak phase, bandwidth (BW), standard deviation (SD), kurtosis, and skewness describe the characteristics of the timing of onset of myocardial contraction and thus degree and severity of LV mechanical dyssynchrony. Previous investigators evaluating the utility of phase analysis in mechanical dyssynchrony focused on using the cut-off of Phase SD of 43°to define significant dyssynchrony. However, it should be noted that Phase SD is a continuous variable, while it correlates well with increasing measures of dyssynchrony such as QRS duration, its use to dichotomize populations into normal vs dyssynchronous using a single-cut point is still based on single-center data that included only patients with wide QRS duration. 10 To date few investigations have focused on dyssynchrony variables as continuous measures occupying the spectrum between normal and diseased myocardium. 11, 12 As GSPECT MPI gains traction as a viable method for assessment of dyssynchrony, it must be evaluated for its diagnostic capabilities, prognostic power, and ultimately the clinical impact of interventions based on different GSPECT MPI-derived dyssynchrony measure cut-offs. Taking a firm step in that direction, in this issue of the journal, Romero-Farina et al. prospectively evaluated 455 patients who underwent clinically indicated GSPECT MPI. This cohort comprised normal patients defined by normal conduction, LV function, and functional capacity and a group of ''abnormal patients'' with either myocardial or conduction disease or both. The investigators applied an algorithm to evaluate the diagnostic or discriminant capability of the dyssynchrony indices for normal and abnormal patients, for those with conduction vs myocardial disease, and for those with indications for CRT. Not surprisingly, the cut-off values defining ''abnormal'' myocardium were relatively low with Phase SD [18°and BW[51°, suggesting that dyssynchrony measures may serve as sensitive indicators of myocardial disease. In addition, in this sizeable study, where a large female representation made a sex-specific analysis possible, the cut-off for dyssynchrony was found to be lower for females compared with males. The cut-offs increased for discrimination between conduction and myocardial disease and cut-offs similar to that reported by Henneman et al. were noted for patients with and without criteria for CRT.
The authors should be lauded for a detailed analysis that represents a true attempt at defining cut-offs and normal distribution of phase analysis dyssynchrony parameters derived from GSPECT MPI. They applied robust statistical methods to define dichotomy points allowing differentiation between varying levels of LV dysfunction. This work also underscores the fact that LV mechanical dyssynchrony probably accompanies diseased myocardium across the spectrum, i.e., larger LV volumes, lower systolic function, and wider QRS duration are associated with a wider dispersion of the time of onset of myocardial contraction.
Despite the commended work from Romero-Farina et al., the critical question remains How does one use this information in clinical practice and what does this mean for the patient in terms of outcomes? It is imaginable that a ''dyssynchrony index'' comprises from a combination of clinical, electrocardiographic, and non-invasive imaging parameters such as the ones from GSPECT MPI could be used to more precisely guide therapy to further improve outcomes. For example, identification of poor function with significant dyssynchrony associated with myocardial infarctions especially at the site of possible LV lead placement is unlikely to improve outcomes by CRT. Therefore, the next few steps in the search towards finding the perfect cut-offs from GSPECT MPI parameters for mechanical dyssynchrony include the use of different gold standards. These should include but not limited to response to CRT as an outcome and ultimately significant clinical events such as hospitalizations for heart failure, cardiac, and all cause mortality.
Preliminary work from Hess et al. shows that there is a relationship between dyssynchrony parameters and outcomes. In their study of over a thousand patients referred for SPECT MPI for evaluation of known or suspected CAD, increase in both cardiovascular and all cause mortality was noted with increasing in BW. Their data, similar to the work of Romero-Farina et al., support the idea of dyssynchrony representing diseased myocardium. While dyssynchrony on a continuous scale is probably useful in prognostication, for clinical decision making, cut-offs are generally helpful. The ideal model for dyssynchrony should include all parameters that SPECT MPI is capable of reporting and which carry implications for CRT implantation and response. For example, a model which includes variables such as clinical information, ejection fraction, Phase SD, BW, regions of earliest and latest contraction, presence or absence of scar, presence of scar at the site of anticipated LV lead placement must be tested for its utility in predicting response to CRT and ultimately patients outcomes (Figure 1 ).
Disclosure
Dr Borges-Neto received research Grant support from GE Health. Dr Samad has no relevant disclosures.
